Evaluation of Maxillary Expansion Methods on Nasomaxillary Structures

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15+
SponsorMerve Kulaksız

About this trial

Maxillary transverse deficiency is an orthodontic anomaly characterized by the upper and lower dental arches being incompatible due to insufficient width of the maxilla. This condition typically manifests with clinical symptoms such as crossbite, crowding of teeth, and impaired respiratory function. Genetic factors, early primary tooth loss, mouth breathing, thumb sucking, and abnormal swallowing are among the causes of maxillary narrowing. Treatment options vary depending on the patient's age and the degree of suture closure. In pediatric and adolescent patients, rapid (RPE) or slow (SPE) orthodontic expansion can be achieved with palatal expansion appliances. However, in adult patients, due to the less flexible bone structure of the maxilla, methods such as surgically assisted expansion (SARME) or mini-screw-assisted expansion (MARPE) are preferred. Recent studies have shown that MARPE can be effective as a non-surgical alternative in young adults and can provide direct skeletal expansion without damaging the teeth.

Eligibility criteria

Qualifiers

Diagnosis of maxillary transverse deficiency.

Patients aged 15 years and older.

Presence of unilateral or bilateral crossbite.

Disqualifiers

Severe facial deformities or craniofacial syndromes.

History of previous orthodontic treatment.

Existing pathology or history of surgery related to the paranasal sinuses, nasolacrimal system, or orbital cavity.

Inadequate patient cooperation.

Trial design

Treatments tested in this trial

  • MARPE (Mini-Screw Assisted Rapid Palatal Expansion)
  • SARME (Surgically Assisted Rapid Maxillary Expansion)

Treatment groups

30 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Merve Kulaksız

Lead sponsor

Bezmialem Vakif University

Sponsor institution